MedTrace Logo

Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy

NCT04629560 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2020-11-16

No results posted yet for this study

Summary

Purpose and Objective: Compare the incidence of taste alteration in treatment vs. control arms and Compare weight loss in treatment vs. control arms

Conditions

  • Taste, Altered
  • Dysgeusia

Interventions

DRUG

Miracle Fruit

one miracle fruit tablet of 100 mg 10-15 minutes before lunch and dinner versus supportive measures. Patients assigned to receive the miracle fruit will receive written instructions regarding the use of the fruit. Patients should put the fruit tablet or powder in the mouth and gently chew/suck to dissolve and cover the tongue with the powder

Sponsors & Collaborators

  • Mt. Sinai Medical Center, Miami

    lead OTHER

Principal Investigators

  • Mike Cusnir, MD · Mount Sinai Medical Center of Florida

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-18
Primary Completion
2011-06-20
Completion
2011-06-20
FDA Drug
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04629560 on ClinicalTrials.gov